永順控股香港(06812.HK)中期純利約為1040萬港元 下跌約74.2%
格隆匯11月22日丨 永順控股香港(06812.HK)公吿,截至2021年9月30日止6個月的中期業績,期內收益約為2.4億港元,下跌約8.2%。期內純利約為1040萬港元,下跌約74.2%;期內獲得新項目總值約3480萬港元,新項目增加約1160萬港元;於2021年9月30日,未完成合約價值約為6.13億港元。
由於COVID-19疫情及實施旅遊限制,集團航空餐飲支援服務業務自2020年3月起直至現時為止一直暫時停擺。因此,期間及截至2020年9月30日止同期並無自此業務分部錄得收益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.